tirzepatide for cardiovascular disease In patients with type 2 diabetes and atherosclerotic disease, was noninferior to dulaglutide with respect to major cardiovascular events. Read the full SURPASS-CVOT trial Tirzepatide is widely known for

This schedule: Reduces the need for multiple daily doses Improves adherence to treatment Fits seamlessly into busy lifestyles The weekly dosing schedule also helps patients maintain consistent glycemic control without the burden of daily injections, which is often a barrier to effective diabetes management

If irritation continues to occur, apply an over-the-counter itch cream, preferably with hydrocortisone

Minor injection site bruising can occur as a local reaction to the subcutaneous injection, but this is typically mild and self-limiting rather than representing a systemic bleeding risk

A.FuentesJ

Among the largest employers, those with 20,000 or more employees, the coverage rate was even higher at 64 percent